MedPage Today on MSN17h
High Price of GLP-1 Agents Tip Cost-Benefit Scale UnfavorablyDespite substantial health benefits, two GLP-1 receptor agonists weren't cost-effective at their current prices, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback